Clinical Trials Directory

Trials / Unknown

UnknownNCT00168623

Vitamin A Supplementation With Routine Childhood Vaccines and Mortality and Morbidity

Randomised Trial of Vitamin A Supplementation Given With Routine Childhood Vaccines at National Immunisation Days

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
6,200 (planned)
Sponsor
Bandim Health Project · Academic / Other
Sex
All
Age
6 Months – 5 Years
Healthy volunteers
Not accepted

Summary

Vitamin A supplementation (VAS) is important for the immune system and may interact with different childhood vaccinations. We have hypothesized that the improved survival after VAS may depend on vitamin A amplifying the non-specific immune modulation induced by vaccinations. In the present study we used information collected in connection with a national vitamin A campaign in Guinea-Bissau during which different doses of VAS was provided together with missing doses of DTP, OPV, and measles vaccines. We aimed to study the potential interactions between VAS and vaccine type.

Detailed description

Vitamin A supplementation (VAS) acts as an adjuvant to vaccines, and VAS has been shown to enhance both cellular and humoral immune responses in animals and in humans. Routine childhood vaccinations have recently been shown to have important non-targeted effects on mortality, i.e. effects that cannot be explained merely by the prevention of the targeted disease. We have hypothesized that the improved survival after VAS may depend not only on the prevention of vitamin A deficiency, but also on vitamin A amplifying the non-specific immune modulation induced by routine vaccinations. In the present study we used information collected in connection with a national vitamin A campaign in Guinea-Bissau during which different doses of VAS was provided together with missing doses of DTP, OPV, and measles vaccines. We aimed to study the potential interactions between VAS and vaccine type.

Conditions

Interventions

TypeNameDescription
DRUGVitamin A

Timeline

Start date
2003-11-01
Completion
2014-12-01
First posted
2005-09-15
Last updated
2013-11-15

Locations

1 site across 1 country: Guinea-Bissau

Source: ClinicalTrials.gov record NCT00168623. Inclusion in this directory is not an endorsement.